Loading...
Lanxess AG
LXS.DE•XETRA
Basic Materials
Chemicals - Specialty
€23.58
€-1.24(-5.00%)
Lanxess AG (LXS.DE) Financial Performance & Income Statement Overview
Review Lanxess AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-5.18%
↓ 5.18%
Operating Income Growth
95.81%
↑ 95.81%
Net Income Growth
-139.95%
↓ 139.95%
Operating Cash Flow Growth
-39.38%
↓ 39.38%
Operating Margin
0.09%
↑ 0.09%
Gross Margin
21.07%
↑ 21.07%
Net Profit Margin
-2.14%
↓ 2.14%
ROE
-3.04%
↓ 3.04%
ROIC
0.08%
↑ 0.08%
Lanxess AG (LXS.DE) Income Statement & Financial Overview
Review Lanxess AG's (LXS.DE) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.48B | $1.60B | $1.68B | $1.61B |
| Cost of Revenue | $1.18B | $1.25B | $1.31B | $1.33B |
| Gross Profit | $305.00M | $349.00M | $364.00M | $280.00M |
| Gross Profit Ratio | $0.21 | $0.22 | $0.22 | $0.17 |
| R&D Expenses | $22.00M | $27.00M | $27.00M | $28.00M |
| SG&A Expenses | $275.00M | $289.00M | $293.00M | $291.00M |
| Operating Expenses | $328.00M | $325.00M | $336.00M | $319.00M |
| Total Costs & Expenses | $1.51B | $1.57B | $1.65B | $1.65B |
| Interest Income | $2.00M | $1.00M | $1.00M | $2.00M |
| Interest Expense | $40.00M | -$13.00M | $12.00M | $11.00M |
| Depreciation & Amortization | $146.00M | $139.00M | $141.00M | $140.00M |
| EBITDA | $118.00M | $154.00M | $141.00M | $78.00M |
| EBITDA Ratio | $0.08 | $0.10 | $0.08 | $0.05 |
| Operating Income | -$23.00M | $24.00M | $28.00M | -$39.00M |
| Operating Income Ratio | -$0.02 | $0.02 | $0.02 | -$0.02 |
| Other Income/Expenses (Net) | -$45.00M | -$22.00M | -$40.00M | -$62.00M |
| Income Before Tax | -$68.00M | $2.00M | -$12.00M | -$73.00M |
| Income Before Tax Ratio | -$0.05 | $0.001 | -$0.007 | -$0.05 |
| Income Tax Expense | -$4.00M | $0.00 | $4.00M | -$21.00M |
| Net Income | -$64.00M | $1.00M | -$16.00M | -$98.00M |
| Net Income Ratio | -$0.04 | $0.001 | -$0.010 | -$0.06 |
| EPS | -$0.74 | $0.01 | -$0.19 | -$1.13 |
| Diluted EPS | -$0.74 | $0.01 | -$0.19 | -$1.13 |
| Weighted Avg Shares Outstanding | $86.35M | $86.35M | $86.35M | $86.35M |
| Weighted Avg Shares Outstanding (Diluted) | $86.35M | $86.35M | $86.35M | $86.35M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan